Le Lézard
Classified in: Health
Subjects: VET, ATY

New Mexico US Navy Veterans Lung Cancer Advocate Urges a Navy Veteran or Person in New Mexico Who Now Has Lung Cancer and Who Prior to 1982 Had Significant Exposure to Asbestos in The Navy or At Work to Call the Law Firm of Danziger & De Llano-Compensation May Exceed $100,000


SANTA FE, N.M., July 15, 2022 /PRNewswire/ -- The New Mexico US Navy Veterans Lung Cancer Advocate is urging the family of a Navy Veteran or person anywhere in New Mexico to call the remarkable legal team at Danziger & De Llano at 800-864-4000 if they have just been diagnosed with lung cancer and if before 1982 they had significant exposure to asbestos in the navy or their workplace. Financial compensation for a person like this might exceed $100,000 if the individual with lung cancer can recall the specifics of how they were exposed to asbestos in the navy or at work. https://meso.dandell.com

The Advocate says, "We are passionate advocates for Navy Veterans and people who had heavy or extreme exposure to asbestos in the navy or at work prior to 1982 and who have been diagnosed with lung cancer within the last 12 months. We want a person like this in New Mexico or nationwide to get compensated-which as mentioned might be substantial. If you have just been diagnosed with lung cancer and before 1982 you had heavy to extreme exposure to asbestos in the navy or at work, please call the remarkable legal team at Danziger & De Llano at 800-864-4000. We are confident you will be glad you did." https://meso.dandell.com

The New Mexico US Navy Veterans Lung Cancer Advocate's free services are available to people with asbestos exposure lung cancer or mesothelioma in Albuquerque, Las Cruses, Rio Rancho, Enchanted Hills, Santa Fe, Roswell, Clovis or anywhere in New Mexico. 

High-risk work groups for exposure to asbestos in New Mexico include US Navy Veterans, civilian workers at one of New Mexico's air force bases, workers at one of New Mexico's dozen-plus power plants, oil refinery workers, civilian employees of the Defense Department, manufacturing, or industrial workers, public utility workers, plumbers, electricians, auto mechanics, machinists, miners, or construction workers. Typically, the exposure to asbestos occurred in the 1960's, 1970's, or 1980's. https://meso.dandell.com 

States with the highest incidence of lung cancer include Kentucky, West Virginia, Maine, Tennessee, Mississippi, Ohio, Indiana, Louisiana, Arkansas, Missouri, North Carolina, Rhode Island, Alabama, and Delaware.

However, asbestos exposure lung cancer can happen in any state including California, New York, Texas, Florida, Massachusetts, Connecticut, Pennsylvania, New Jersey, Illinois, Wisconsin, Minnesota, Nebraska, New Mexico, North Dakota, Wyoming, Utah, Montana, Idaho, Arizona, Washington, Oregon, or Alaska.

For more information about asbestos exposure please visit the NIH's website on this topic: https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos/asbestos-fact-sheet.

Media Contact:

Michael Thomas
202-422-2069
[email protected]

SOURCE New Mexico US Navy Veterans Lung Cancer Advocate


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: